Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00474 vs URI, SUNB, AER: Days Payable Comparison
For the Rental & Leasing Services subindustry, Aceso Life Science Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aceso Life Science Group Days Payable vs Business Services Industry
For the Business Services industry and Industrials sector, Aceso Life Science Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Aceso Life Science Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aceso Life Science Group's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aceso Life Science Group (HKSE:00474) has a Days Payable of 0.00 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aceso Life Science Group and its competitors. Over the past decade, Aceso Life Science Group's Days Payable has ranged from 11.93 to 128.41. According to the industry distribution chart, Aceso Life Science Group ranks #726 out of 945 companies in the Business Services industry, placing it in the top 76.8%.
Is Aceso Life Science Group's Days Payable too high?
Aceso Life Science Group's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 11.93 to a high of 128.41. Based on the distribution chart, Aceso Life Science Group ranks #726 out of 945 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Aceso Life Science Group has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aceso Life Science Group's Days Payable compare to URI and SUNB?
According to the Business Services industry distribution chart, Aceso Life Science Group ranks #726 out of 945 companies for Days Payable. This places Aceso Life Science Group in the lower half of its industry. The industry median Days Payable is 44.15. Historically, Aceso Life Science Group's own Days Payable has ranged from 11.93 to 128.41 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Business Services company?
The median Days Payable among Business Services companies is 44.15, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aceso Life Science Group and its competitors. For the Business Services industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aceso Life Science Group's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aceso Life Science Group stock overvalued right now?
Based on GuruFocus' analysis, Aceso Life Science Group (HKSE:00474) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.11 — trading 42.5% above its estimated fair value. The current Days Payable is 0.00. Aceso Life Science Group's overall GF Score™ is 19/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aceso Life Science Group (HKSE:00474), the current Days Payable is 0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?
Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued.
The current stock price of HK$0.11 is trading 42.5% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.
Key valuation signals for HKSE:00474:
Days Payable: 0.00
GF Value™: HK$0.08 vs. price of HK$0.11 (42.5% above fair value)
No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score
Get the complete analysis for HKSE:00474
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00474 has been successfully added to your 
